梯瓦制药Teva Pharmaceutical Industries（TEVA）2025年第一季度财报电话会议纪要「NYSE」（英文版）（17页）.pdf

1、 Corrected Transcript 1-877-FACTSET Total Pages:17 Copyright 2001-2025 FactSet CallStreet,LLC 07-May-2025 Teva Pharmaceutical Industries Ltd.(TEVA)Q1 2025 Earnings Call Teva Pharmaceutical Industries Ltd.(TEVA)Q1 2025 Earnings Call Corrected Transcript 07-May-2025 1-877-FACTSET 2 Copyright 2001-2025

2、 FactSet CallStreet,LLC CORPORATE PARTICIPANTS Christopher J.Stevo Senior Vice President-Investor Relations&Competitive Intelligence,Teva Pharmaceutical Industries Ltd.Richard Francis President,Chief Executive Officer&Director,Teva Pharmaceutical Industries Ltd.Eli Kalif Executive Vice President&Chi

3、ef Financial Officer,Teva Pharmaceutical Industries Ltd.Eric A.Hughes Executive Vice President-Global R&D&Chief Medical Officer,Teva Pharmaceutical Industries Ltd.OTHER PARTICIPANTS David Amsellem Analyst,Piper Sandler&Co.Jason M.Gerberry Analyst,BofA Securities,Inc.Umer Raffat Analyst,Evercore ISI

4、Ashwani Verma Analyst,UBS Securities LLC Chris Schott Analyst,JPMorgan Securities LLC Yifeng Liu Analyst,HSBC Bank Plc .MANAGEMENT DISCUSSION SECTION Operator:Hello and welcome to the Q1 2025 Teva Pharmaceutical Industries Limited Earnings Conference Call.My name is Alex.Ill be coordinating the call

5、 today.Operator Instructions.Ill now hand it over to your host,Christopher Stevo,Head of Investor Relations,to begin.Please go ahead.Christopher J.Stevo Senior Vice President-Investor Relations&Competitive Intelligence,Teva Pharmaceutical Industries Ltd.Thank you,Alex.Good morning everyone.In the co

6、urse of this call,were going to be making some forward-looking statements and any statements we make are valid only as of today and we undertake no obligation to update them in the future.And if you have any additional questions on our forward-looking statements,you can see the relevant sections of